| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
Submitted on April 19, 2006
Accepted on June 16, 2006
Unit of Diabetes, Endocrinology and Nutrition, Hospital of Girona Dr. Josep Trueta. Girona. Spain
* To whom correspondence should be addressed. E-mail: uden.jmfernandezreal{at}htrueta.scs.es.
Context: Levels of TSH respond to fluctuations in serum free T4, but remain in a very narrow individual range. There exists current controversy regarding upper limit of normal serum TSH values above which treatment should be indicated.
Objective: We aimed to study whether the individually determined free T4 - TSH relationship was associated with plasma lipids, insulin sensitivity and endothelial dysfunction in healthy subjects with strictly normal thyroid function according to recent recommendations (0.3-3.0 mU/L).
Design: Cross-sectional study.
Setting: A cohort of healthy men from the general population (n = 221).
Main Outcome Measures: Oral glucose tolerance, insulin sensitivity (SI, minimal model), endothelium-dependent vasodilation (high resolution ultrasound) and plasma lipids were measured in relation to thyroid function tests.
Results: Both serum TSH and free T4· TSH product (fT4·TSH) were positively associated with fasting post-load insulin concentration, and negatively with SI. After BMI stratification, these associations were especially significant among lean subjects.
Serum TSH and fT4·TSH product also correlated positively with fasting triglycerides and negatively with HDL cholesterol. In a multiple linear regression analysis, age (P = 0.007) and SI (P = 0.02), but not BMI, fasting triglycerides or serum HDL concentration contributed independently to 3.7% and 3.3%, respectively, of the variance in fT4·TSH. Those subjects over the median of fT4·TSH showed reduced endothelium-dependent vasodilation.
Conclusions: Thyroid function tests are intrinsically linked to variables of insulin resistance and endothelial function. It is possible that underlying factors lead simultaneously to increased serum TSH, insulin resistance, ensuing dyslipidemia and altered endothelial function even within current "normal" TSH levels.
This article has been cited by other articles:
![]() |
M Korada, M S Pearce, M P Ward Platt, E Avis, S Turner, H Wastell, and T Cheetham Repeat testing for congenital hypothyroidism in preterm infants is unnecessary with an appropriate thyroid stimulating hormone threshold Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2008; 93(4): F286 - F288. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O. Asvold, T. Bjoro, T. I. L. Nilsen, D. Gunnell, and L. J. Vatten Thyrotropin Levels and Risk of Fatal Coronary Heart Disease: The HUNT Study Arch Intern Med, April 28, 2008; 168(8): 855 - 860. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |